- Home
- REXR vs CORT Comparison
REXR vs CORT Comparison
Compare REXR & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REXR
- CORT
- Stock Information
- Founded
- REXR 2013
- CORT 1998
- Country
- REXR United States
- CORT United States
- Employees
- REXR N/A
- CORT N/A
- Industry
- REXR Real Estate Investment Trusts
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- REXR Real Estate
- CORT Health Care
- Exchange
- REXR Nasdaq
- CORT Nasdaq
- Market Cap
- REXR 7.7B
- CORT 7.1B
- IPO Year
- REXR 2013
- CORT N/A
- Fundamental
- Price
- REXR $34.67
- CORT $78.69
- Analyst Decision
- REXR Hold
- CORT Strong Buy
- Analyst Count
- REXR 9
- CORT 4
- Target Price
- REXR $39.67
- CORT $142.00
- AVG Volume (30 Days)
- REXR 2.1M
- CORT 1.1M
- Earning Date
- REXR 07-16-2025
- CORT 05-05-2025
- Dividend Yield
- REXR 4.96%
- CORT N/A
- EPS Growth
- REXR 12.67
- CORT 8.36
- EPS
- REXR 1.23
- CORT 1.14
- Revenue
- REXR $974,598,000.00
- CORT $685,446,000.00
- Revenue This Year
- REXR $9.78
- CORT $35.85
- Revenue Next Year
- REXR $8.46
- CORT $35.22
- P/E Ratio
- REXR $28.20
- CORT $68.97
- Revenue Growth
- REXR 18.04
- CORT 30.93
- 52 Week Low
- REXR $29.68
- CORT $27.30
- 52 Week High
- REXR $52.61
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- REXR 49.50
- CORT 62.98
- Support Level
- REXR $33.82
- CORT $74.34
- Resistance Level
- REXR $35.77
- CORT $75.50
- Average True Range (ATR)
- REXR 0.73
- CORT 3.21
- MACD
- REXR 0.11
- CORT 0.50
- Stochastic Oscillator
- REXR 41.98
- CORT 92.19
About REXR Rexford Industrial Realty Inc.
Rexford Industrial Realty Inc is a real estate investment trust engaged in owning, operating, and acquiring industrial properties in Southern California infill markets. The goal is to generate attractive risk-adjusted returns for stockholders by providing superior access to industrial property investments in Southern California infill markets. It has one operating segment business of investing in, operating, and repositioning/redeveloping industrial real estate properties located in Southern California infill markets.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.